1. Home
  2. SLM vs MMED Comparison

SLM vs MMED Comparison

Compare SLM & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SLM Corporation

SLM

SLM Corporation

N/A

Current Price

$25.36

Market Cap

4.2B

Sector

Finance

ML Signal

N/A

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$17.41

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLM
MMED
Founded
1972
1983
Country
United States
United States
Employees
1788
2800
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.3B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
SLM
MMED
Price
$25.36
$17.41
Analyst Decision
Buy
Strong Buy
Analyst Count
11
10
Target Price
$31.09
$22.56
AVG Volume (30 Days)
3.0M
1.0M
Earning Date
04-23-2026
06-03-2026
Dividend Yield
2.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.35
$15.99
Revenue Next Year
$5.68
$10.00
P/E Ratio
$6.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.77
$10.65
52 Week High
$33.17
$17.86

Technical Indicators

Market Signals
Indicator
SLM
MMED
Relative Strength Index (RSI) 56.10 68.77
Support Level $21.00 $14.70
Resistance Level $26.01 N/A
Average True Range (ATR) 0.80 0.92
MACD -0.16 0.09
Stochastic Oscillator 77.14 95.75

Price Performance

Historical Comparison
SLM
MMED

About SLM SLM Corporation

SLM Corp is an education solutions company. Its business is to originate and service loans to students and their families to finance the cost of their education. The term' Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: